Abstract
Drug reaction with eosinophilia and systemic symptoms (DRESS) survivors reported substantial problems with medication adherence and health-related quality of life. Increased recognition of long-term DRESS-associated morbidity and efforts to improve the emotional well-being of DRESS survivors is needed.